Search results for:
Filter content:
Global health evaluation in a dynamic context: Lessons from COVAX
Itad’s review of the COVAX Facility and AMC demonstrated a critical role for independent evaluation in unpacking high-profile, political and...
Itad’s COVAX evaluation provides rich insights for future pandemic responses
A newly-published Itad evaluation of the COVAX Facility and Advanced Market Commitment provides a balanced critique and lessons for pandemic...
End-point evaluation of the UK Public Health Rapid Support Team (UK-PHRST) – final report
Findings, conclusions and recommendations from our evaluation of the UK Public Health Rapid Support Team
Learning to go virtual: Our highlights from the WISH Learning Event
In early December 2020, Itad facilitated the annual Women’s Integrated Sexual Health (WISH) Programme Learning Event. In our role as Third...
Fairness beyond the race: Four questions for COVID-19 vaccine equity
The COVID-19 pandemic has seen an unprecedented response from the international community to address what will happen when a vaccine comes out....
As global health players pivot to COVID-19 responses, we need coordinated, real-time, formative evaluations
An estimated $15.9 trillion has been mobilised to respond to the health and economic impact of the COVID-19 pandemic. Some of this has gone to...
Epidemics and NTDs: Avoiding further neglect
Previous epidemics have taught us that essential services such as access to NTD (neglected tropical disease) programmes can almost grind to a...
COVID-19 and sexual and reproductive health: Lessons from Zika and Ebola
The need to rapidly learn from previous experience and evidence on sexual and reproductive health in epidemics is now an urgent task. Members of...
